Amir Kaki, MD discusses tips, tricks and techniques for high-risk PCI including access, implant, explant, closure, and complications and sheath management.
James Park, MD, presents a patient with cardiogenic shock supported with the Impella heart pump prior to revascularization and describes other best practices at his center.
Impella “reduced major adverse events, critical care and readmission length of stay, and readmission cost over the 90-day EOC (episode of care), and was determined to be cost-effective over the long-term.”
Data from the PROTECT II randomized controlled trial show that patients treated with Impella had numerically lower rates of vascular complications compared with patients treated with intra-aortic balloon pump (1.4% for Impella versus 1.9% for IABP).1
